Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 66 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9333244

    Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia

    HALOZYME, INC. · Granted May 10, 2016 · Expires May 5, 2036

    granted

  2. US 9334246

    Substituted triazines for malaria treatment and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted May 10, 2016 · Expires May 5, 2036

    granted

  3. US 9334250

    Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 10, 2016 · Expires May 5, 2036

    granted

  4. US 9333171

    Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted May 10, 2016 · Expires May 5, 2036

    granted

  5. US 9327023

    HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  6. US 9328387

    Antipsychotic treatment based on SNP genotype

    VANDA PHARMACEUTICALS INC. · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  7. US 9320786

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  8. US 9314507

    Methods of treatment of heart failure with natriuretic peptides

    Capricor Therapeutics, Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  9. US 9314448

    Method of inhibiting ABCG2 and other treatment methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  10. US 9301947

    Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  11. US 9303066

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  12. US 9303044

    7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  13. US 9303077

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  14. US 2016089368

    TREATMENT OF MASTOCYTOSIS WITH MASITINIB

    AB SCIENCE [FR] · Granted Mar 31, 2016 · Expires Mar 26, 2036

    granted

  15. US 9295674

    Metalloporphyrin neurological treatments

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  16. US 9289398

    Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith

    PTC THERAPEUTICS, INC. · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  17. US 9290474

    Methods for making and using novel semi-synthetic small molecules for the treatment parasitic disease

    The Regents of the University of California · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  18. US 9289513

    Targeted cytokine for treatment of musculoskeletal diseases

    OPTION PHARMACEUTICALS, LLC · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  19. US 9283185

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted

  20. US 9278116

    Compositions and methods for treatment of pain

    Princeton Biotechnology Corporation · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  21. US 9278091

    Compounds for the treatment of Clostridium difficile associated disease

    SUMMIT THERAPEUTICS PLC · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  22. US 9272990

    Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis

    AMIRA PHARMACEUTICALS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  23. US 9272034

    Treatment of conditions related to shock

    The Regents of the University of California · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  24. US 2016051546

    CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Feb 25, 2016 · Expires Feb 20, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.